EU drug agency starts evaluating new COVID-19 treatment
The European Union’s medicines authority said Thursday that it is evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease.
Xevudy,…
Read More...
Read More...